United States v. AION Management, LLC

District Court, D. Delaware·Decided June 26, 2025·No. 1:23-cv-00742·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE UNITED STATES OF AMERICA, ) ) Plaintiff, ) ) and ) ) FAIR HOUSING PARTNERSHIP OF ) GREATER PITTSBURGH, INC. et al., ) Civil Action No. 23-742 (GBW) ) Plaintiffs-Intervenors, ) ) v. ) ) AION MANAGEMENT, LLC, et ai., ) ) Defendants. ) )

MEMORANDUM ORDER Before the Court is Defendants AION Management, LLC, Leland Point Owner, LP, AP Cosmopolitan, LLC, AP Greenspring, LLC, AP Livingstone, LLC, AION University Village, LLC, AP East Pointe, LLC, and AP Hunters Crossing, LLC’s (collectively, “Defendants”) Motion for Reconsideration of the Order Denying the Motion to Dismiss the Amended Complaint and Complaint in Intervention and, in the alternative, Motion to Certify the Order Denying Defendants’ Motion to Dismiss for Interlocutory Appeal (D.I. 37) (“the Motions”). The United States filed an Answering Brief in opposition to the Motions (D.I. 43); and the Fair Housing Partnership of Greater Pittsburgh, Inc, the Housing Equality Center of Pennsylvania, and the National Fair Housing Alliance (collectively, “Intervenors,” and with the United States, “Plaintiffs”) filed an Answering Brief in opposition to the Motions. (D.I. 42; D.I. 43). For the

reasons explained below, the Court DENIES the Motion for Reconsideration and DENIES the Motion to Certify for Interlocutory Appeal (D.I. 37). L BACKGROUND! On March 18, 2025, the Court issued an Order denying Defendants’ Motion to Dismiss the United States’ First Amended Complaint and denying Defendants’ Motion to Dismiss the Intervenors’ Complaint (D.I. 34) (“the Order”). The Order was accompanied by a Memorandum Opinion, which explained the Court’s reasoning (D.I. 33) (“the Opinion”). On April 15, 2025, Defendants filed a Motion for Reconsideration of the Order and, in the alternative, a Motion to Certify the Order for Interlocutory Appeal. (D.I 37; D.I. 37, Ex. 1 (Defendants’ Brief in Support)). On May 13, 2025, Intervenors filed an Answering Brief in opposition to the Motion for Reconsideration and the Motion to Certify for Interlocutory Appeal. (D.I. 42). That same day, the United States filed an Answering Brief in opposition to the Motion for Reconsideration and the Motion to Certify for Interlocutory Appeal. (D.I. 43). II. THE MOTION FOR RECONSIDERATION A. Legal Standard Defendants move for reconsideration “pursuant to Federal Rule of Civil Procedure 59(e) and/or Federal Rule of Civil Procedure 60(b).” (D.I.37 at 1). However, neither Federal Rule of Civil Procedure 59(e) (“Rule 59(e)”) nor Federal Rule of Civil Procedure 60(b) (“Rule 60(b)”) apply here. Rule 59(e) governs motions to alter or amend “a judgment.” Fed. R. Civ. P. 59(e). Similarly, Rule 60(b) provides relief “from a final judgment, order, or proceeding.” Fed. R. Civ. P. 60(b). The Court’s Order, which denied Defendants’ Motion to Dismiss, is not a “judgment”

| The Court writes for the parties, who are familiar with the factual background and the allegations in the United States’ First Amended Complaint (D.I. 12) and in Plaintiffs- Intervenors’ Complaint (D.I. 22) (together, “the Complaints”).

for purposes of Rule 59(e) or a “final judgment, order, or proceeding” for purposes of Rule 60(b). See Pellicano v. Blue Cross Blue Shield Ass’n, 540 Fed. App’x 95, 98 n. 4 (3d Cir. 2013). Instead, non-final orders, like the Order, are considered interlocutory orders. Rule 59(e) and Rule 60(b) “only provide for reconsideration of final judgments, not interlocutory orders.” Gay v. A.O. Smith Corp., Civil Action No. 2:19-1311, 2022 WL 2829887, 2022 U.S. Dist. LEXIS 131907, at *13-14 (W.D. Pa. Apr. 21, 2022); see also Warner v. Twp. of S. Harrison, 885 F. Supp. 2d 725, 747 (D.N.J. 2012) (same). Motions to review interlocutory orders invoke “the district court’s general discretionary authority to review and revise interlocutory rulings prior to entry of final judgment.” Pellicano, 540 Fed. App’x at 98 n.4 (citing Wagoner v. Wagoner, 938 F.2d 1120, 1122 n.1 (10th Cir. 1991)); see also Dayoub v. Penn-Del Directory Co., 90 F. Supp. 2d 636, 637 (E.D. Pa. 2000). A district court should reconsider an interlocutory order when “it is consonant with justice to do so.” United States v. Jerry, 487 F.2d 600, 605 (3d Cir. 1973); see also Anthanassious v. Palmer, 418 Fed. App’x 91, 95 (3d Cir. 2011) (“[A] trial judge has the discretion to reconsider an issue and should exercise that discretion whenever it appears that a previous ruling, even if unambiguous, might lead to an unjust result.”) (citation and quotation marks omitted). There is, however, “a presumption against reconsideration of interlocutory decisions;” and, “as a rule[,] courts should be loathe to do so in the absence of extraordinary circumstances.” Jd. at 96; Bellevue Drug Co. v. CaremarksPCS, 582 F.3d 432 (3d Cir. 2009) (quoting Christianson v. Colt Indus. Operating Corp., 486 U.S. 800, 816 (1988)). B. Analysis Defendants assert that the Court should reconsider the Order for the following reasons: (1) the Court erroneously found that “necessity” was plead in the Complaints; (2) the Third Circuit has “foreclose[d] liability for a violation of Section 3604(f)(3)(B) in a ‘tester’ case;” (3) the Court

“refused to recognize that Plaintiffs’ [Section] 3604(c) claims arise solely from conduct purportedly violating [Section] 3604(f)(3)(b);” and (4) Plaintiffs do not have organizational standing under FDA v. Alliance for Hippocratic Medicine, 602 U.S. 367 (2024) (“Alliance”). (D.I. 37, Ex. 1 at 12, 14, 17-20). The Court briefly addresses each of these arguments below. 1. Necessity is Plausibly Alleged in the Complaints First, Defendants contend that the Court “began and ended its analysis of ‘necessity’... by concluding that the testers’ mere utterance or implication of the word ‘necessary’ in the course of their tests” was sufficient to plead a claim under Section 3604()(3)(B). (D.L. 37, Ex. 1 at 13). Defendants’ characterization of the Court’s analysis is incorrect. (See D.I. 42 at 8-9; D.I. 43 at 14-17, 22-23). The Court carefully analyzed the allegations in the Complaints and concluded that Plaintiffs had plausibly alleged that the testers informed Defendants of various physical impairments from which it was reasonable to infer that an assigned parking space would be necessary. (D.I. 33 at 35-38 (quoting D.I. 12 JJ 22-39; D.I. 22 Ff 24-53); see also D.I. 42 at 9 (“[T]he Court credited, specific [alleged] physical impairments from which an assigned parking space would plausibly be necessary, including that testers’ family members used canes, crutches, or walkers, were unable to walk more than 100 feet, and experienced fatigue after walking long distances.”)).

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. AION Management, LLC, (D. Del. 2025).

United States v. AION Management, LLC (United States v. AION Management, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Christianson v. Colt Industries Operating Corp.
486 U.S. 800 (Supreme Court, 1988)
West Penn Allegheny Health System, Inc. v. UPMC
627 F.3d 85 (Third Circuit, 2010)
United States v. Bernard Jerry, and Edgar Saunders
487 F.2d 600 (Third Circuit, 1973)
Bachowski v. Usery
545 F.2d 363 (Third Circuit, 1976)
Kapossy v. McGraw-Hill, Inc.
942 F. Supp. 996 (D. New Jersey, 1996)
Dayoub v. Penn-Del Directory Co.
90 F. Supp. 2d 636 (E.D. Pennsylvania, 2000)
Carol Vorchheimer v. Philadelphian Owners Associati
903 F.3d 100 (Third Circuit, 2018)
Access Living of Metropolitan Chicago v. Prewitt
111 F. Supp. 3d 890 (N.D. Illinois, 2015)
Bellevue Drug Co. v. CaremarksPCS, Inc.
582 F.3d 432 (Third Circuit, 2009)
Barbato v. Greystone Alliance, LLC
916 F.3d 260 (Third Circuit, 2019)
Warner v. Township of South Harrison
885 F. Supp. 2d 725 (D. New Jersey, 2012)
Weske v. Samsung Electronics, America, Inc.
934 F. Supp. 2d 698 (D. New Jersey, 2013)
Isbell v. Bellino
962 F. Supp. 2d 738 (M.D. Pennsylvania, 2013)
FDA v. Alliance for Hippocratic Medicine
602 U.S. 367 (Supreme Court, 2024)